硬性内視鏡市場規模、シェア、動向、2030年までの世界予測

硬性内視鏡市場 – タイプ（腹腔鏡、関節鏡、膀胱鏡）、臨床用途（診断、外科）、用途（腹腔鏡検査、膀胱鏡検査、関節鏡検査、その他）、エンドユーザー（病院、ASC、クリニック）、地域別 – 2030年までの世界予測

世界の硬性内視鏡市場は、2025年の18億3,000万米ドルから2030年には23億2,000万米ドルに達し、予測期間中に4.9%の年平均成長率（CAGR）で成長すると予測されています。硬性内視鏡市場の成長は、慢性疾患の罹患率の上昇、低侵襲手術の需要増加、そして画像・光学技術の進歩に牽引されています。新興市場では、医療インフラの拡大、手術件数の増加、そして医療ツーリズムの台頭により、高度な内視鏡ソリューションの導入機会が存在します。しかしながら、市場の成長は、ウイルス感染のリスク、適切な滅菌・再処理の欠如、そして高額な手術費用といった課題に直面しており、特に資源が限られた地域では、これらのリスクが広範な導入を制限する可能性があります。

本レポートは、硬性内視鏡市場をタイプ、用途、エンドユーザー、地域別に分析しています。また、市場の成長に影響を与える主要要因（促進要因、抑制要因、機会、課題など）を分析するとともに、市場リーダーの競争環境を詳細に分析しています。さらに、ミクロ市場を個々の成長傾向の観点から分析しています。さらに、5つの主要地域（および各地域に属する国）における市場セグメントの収益予測も提供しています。

本レポートは、既存企業だけでなく、新規参入企業も市場の動向を把握し、市場シェアの拡大に役立てることができます。本レポートを購入した企業は、以下の戦略のいずれか、または組み合わせて活用することで、市場プレゼンスを強化できます。

本レポートでは、以下の点について考察します。

• 主要な推進要因（政府およびその他の組織による投資、資金、助成金の増加、病院による内視鏡ユニットの拡充への注力、低侵襲手術への関心の高まり、対象疾患の診断・治療における内視鏡検査の必要性の高まり）、制約要因（内視鏡検査にかかる高額な間接費、内視鏡検査中の感染リスクの増大）、機会（新興国におけるヘルスケアセクターの急速な発展）、課題（製品リコールの増加、滅菌・再処理の不足）の分析
• 市場浸透：硬性内視​​鏡市場における主要企業の製品ラインナップに関する徹底的な知識
• 製品開発／イノベーション：硬性内視​​鏡市場における今後のトレンド、研究開発イニシアチブ、新製品投入に関する包括的な理解
• 市場開拓：収益性の高い発展途上地域に関する徹底的な知識
• 市場多様化：新製品、拡大する地域、硬性内視鏡業界における最新の変化に関する徹底的な知識は、市場の多様化に役立ちます
• 競合評価：オリンパス株式会社（日本）、Karl Storz SE & CO. KG（ドイツ）、Stryker（米国）、ニプロ株式会社（日本）、EndoMed Systems GmbH（ドイツ）、Richard Wolf GmbH（ドイツ）、Ambu A/S（デンマーク）、Smith+Nephew（英国）などの主要企業の市場シェア、成長戦略、製品ラインナップに関する詳細な評価

Report Description

The global rigid endoscopes market is projected to reach USD 2.32 billion by 2030, growing from USD 1.83 billion in 2025, at a CAGR of 4.9% during the forecast period. The growth of the rigid endoscopes market is driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive surgeries, and advancements in imaging and optics technology. Opportunities exist in emerging markets due to the expansion of healthcare infrastructure, increasing procedural volumes, and rising medical tourism, which enable the adoption of advanced endoscopic solutions. However, market growth faces challenges from risks of viral infections, lack of proper sterilization and reprocessing, and high procedural costs, which may limit widespread adoption, particularly in resource-constrained regions.

The arthroscopes segment is expected to grow at the fastest rate in the rigid endoscopes market during the forecast period.

By type, the rigid endoscopes market is segmented into laparoscopes, urology endoscopes, gynecology endoscopes, arthroscopes, cytoscopes, neuroendoscopes, and other rigid endoscopes. Among these, the urology endoscopes segment accounted for the second-largest market share in 2024, owing to the increasing prevalence of musculoskeletal disorders, particularly among the aging global population. According to the WHO, the number of people aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, creating a substantial patient pool at higher risk for joint-related conditions. Age-related degenerative diseases such as osteoarthritis are becoming more common, with the CDC reporting that arthritis prevalence increases sharply with age—from 3.6% in adults aged 18–34 to 53.9% in individuals 75 and older—driving demand for minimally invasive orthopedic interventions. Arthroscopy offers a precise, less invasive solution for diagnosing and treating joint injuries, reducing recovery time, and improving surgical outcomes, which enhances patient preference and procedural adoption. Additionally, advancements in high-definition imaging, improved surgical instruments, and growing awareness among orthopedic specialists are further accelerating the adoption of arthroscopes, positioning this segment for the fastest growth within the rigid endoscopes market.

The surgical usage segment accounted for the largest share of the rigid endoscopes market in 2024.

By clinical usage, the rigid endoscopes market has been divided into diagnostic & surgical usage. Among these, the surgical usage segment accounted for the largest share of the market in 2024. This is due to the increasing adoption of minimally invasive procedures across multiple specialties, including laparoscopy, arthroscopy, urology, gynecology, and ENT. Rigid endoscopes serve as the core platform for these interventions, offering superior optical clarity, high-definition and 4K visualization, and robust, autoclavable designs that integrate seamlessly with surgical instruments and operating room workflows. The growing preference for minimally invasive surgeries is driven by benefits such as shorter hospital stays, reduced post-operative complications, faster patient recovery, and enhanced clinical outcomes, which directly influence procedure volumes and market demand for rigid scopes.

Asia Pacific is projected to grow at the highest rate in the rigid endoscopes market during the forecast period.

The global rigid endoscopes market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Among these, the Asia Pacific region is projected to grow at the highest rate during the forecast period. This is primarily due to the development of healthcare infrastructure, increasing healthcare expenditure, and rising awareness of early disease detection across populous nations such as China and India. These countries are investing heavily to enhance diagnostic and surgical capabilities, particularly to manage the rising cases of chronic diseases, such as cancer, pulmonary, and urological disorders. Japan’s well-established healthcare system with universal insurance coverage ensures wide accessibility to advanced endoscopic procedures. Moreover, increasing medical tourism, favorable government initiatives, and the rising adoption of minimally invasive technologies are accelerating market penetration, making the Asia Pacific a high-growth region in the global rigid endoscopes market.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 –40%, Tier 2 –30%, and Tier 3 –30%
• By Designation: C-level –50%, Director level –30%, and Others –20%
• By Region: North America –30%, Europe – 25%, Asia Pacific –20%, Latin America –15%, and Middle East & Africa –10%

Notes:

Companies are classified into tiers based on their total revenue. The tiers are as follows: Tier 1 = >USD 10.0 billion, tier 2 = USD 1.0 billion to USD 10.0 billion, and tier 3 = <USD 1.0 billion

C-level primaries include CEOs, CFOs, COOs, and VPs.

Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The players operating in the rigid endoscopes market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), B Braun SE (Germany), CONMED Corporation (US), Arthrex Inc. (US), Nipro (Japan), FUJIFILM Corporation (Japan), Hologic, Inc. (US), Shangrao WS Medtech Co., Ltd (China), Henke-Sass, Wolf (Germany), RUDOLF Medical GmbH + Co. KG (Germany), EndoMed Systems GmbH (Germany), Teleflex Incorporated (US), Integrated Endoscopy (US), NeoScope, Inc. (US), Ecleris (US), Nanchang WOEK Medical Technology Co., Ltd (China), Richard Wolf GmbH. (Germany), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Kashmir Surgical Works. (India), Optomic (Spain), and HIPP ENDOSKOP SERVICE GMBH (Germany)

Research Coverage

This report examines the rigid endoscopes market by type, application, end user, and region. The report also examines key factors (including drivers, restraints, opportunities, and challenges) influencing market growth and provides an in-depth analysis of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends. It forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as smaller entrants to gauge the market’s pulse, which, in turn, will help them gain a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing investments, funds, and grants by government and other organizations, growing focus of hospitals to expand endoscopic units, increasing preference for minimally invasive surgeries, rising need for endoscopy to diagnose & treat target diseases), restraints (high overhead costs of endoscopy procedures, increased risk of getting infections during endoscopic procedures), opportunities (rapidly developing healthcare sector in emerging countries), challenges (increasing number of product recalls, lack of sterilization & reprocessing)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the rigid endoscopes market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the rigid endoscopes market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the rigid endoscopes industry helps to diversify the market
• Competitive Assessment: In-depth assessment of market share, growth strategies, and product offerings of leading players like Olympus Corporation (Japan), Karl Storz SE & CO. KG (Germany), Stryker (US), Nipro (Japan), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), Ambu A/S (Denmark), Smith+Nephew (UK), and others.

Table of Contents

1               INTRODUCTION              23

1.1           STUDY OBJECTIVES       23

1.2           MARKET DEFINITION   23

1.3           STUDY SCOPE   24

1.3.1        MARKET SEGMENTATION & REGIONAL SCOPE 24

1.3.2        INCLUSIONS & EXCLUSIONS       25

1.3.3        YEARS CONSIDERED      26

1.3.4        CURRENCY CONSIDERED            26

1.4           STAKEHOLDERS               27

2               RESEARCH METHODOLOGY       28

2.1           RESEARCH DATA              28

2.1.1        SECONDARY DATA          29

2.1.1.1    Key objectives of secondary research                 29

2.1.1.2    Key data from secondary sources       30

2.1.2        PRIMARY DATA 30

2.1.2.1    Key primary sources             31

2.1.2.2    Key objectives of primary research    31

2.1.2.3    Key industry insights           32

2.1.2.4    Key data from primary sources           33

2.2           MARKET SIZE ESTIMATION         34

2.2.1        SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)                 34

2.2.2        TOP-DOWN APPROACH                35

2.2.3        COMPANY PRESENTATIONS & PRIMARY INTERVIEWS                 35

2.2.4        DEMAND-SIDE ANALYSIS (USING RIGID ENDOSCOPES)                 35

2.3           DATA TRIANGULATION                38

2.4           MARKET RANKING ANALYSIS     39

2.5           STUDY ASSUMPTIONS  39

2.6           RESEARCH LIMITATIONS             39

2.6.1        METHODOLOGY-RELATED LIMITATIONS           39

2.6.2        SCOPE-RELATED LIMITATIONS                 40

2.7           RISK ASSESSMENT           40

3               EXECUTIVE SUMMARY  41

4               PREMIUM INSIGHTS       45

4.1           RIGID ENDOSCOPES MARKET OVERVIEW            45

4.2           NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER AND COUNTRY           46

4.3           RIGID ENDOSCOPES MARKET: GEOGRAPHIC MIX                 47

4.4           RIGID ENDOSCOPES MARKET: EMERGING VS. DEVELOPED ECONOMIES            48

5               MARKET OVERVIEW       49

5.1           INTRODUCTION              49

5.2           MARKET DYNAMICS       49

5.2.1        DRIVERS               50

5.2.1.1    Growing preference for minimally invasive surgeries     50

5.2.1.2    Increasing burden of chronic and lifestyle-related diseases                 50

5.2.2        RESTRAINTS      51

5.2.2.1    High overhead costs             51

5.2.2.2    Risk of viral infections during endoscopic procedures   51

5.2.3        OPPORTUNITIES              52

5.2.3.1    Rapidly developing healthcare sector in emerging economies                 52

5.2.4        CHALLENGES    52

5.2.4.1    Product recalls      52

5.2.4.2    Lack of sterilization and reprocessing               53

5.3           INDUSTRY TRENDS         54

5.3.1        ADVANCED IMAGING TECHNOLOGIES 54

5.3.2        MINIATURIZATION AND ULTRA-SLIM DESIGNS                 54

5.4           TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            54

5.5           PRICING ANALYSIS          55

5.5.1        AVERAGE SELLING PRICE TREND A OF RIGID ENDOSCOPES,

BY KEY PLAYER, 2022–2024            55

5.5.2        AVERAGE PRICING TREND OF RIGID ENDOSCOPES, BY REGION, 2022–2024           56

5.6           VALUE CHAIN ANALYSIS               57

5.7           SUPPLY CHAIN ANALYSIS             58

5.8           ECOSYSTEM ANALYSIS  60

5.9           INVESTMENT & FUNDING SCENARIO     61

5.10         TECHNOLOGY ANALYSIS             61

5.10.1      KEY TECHNOLOGIES     62

5.10.1.1  Illumination technology       62

5.10.2      COMPLEMENTARY TECHNOLOGIES       62

5.10.2.1  Surgical visualization           62

5.10.3      ADJACENT TECHNOLOGIES       62

5.10.3.1  3D endoscopic visualization                62

5.11         TRADE ANALYSIS             63

5.11.1      IMPORT DATA FOR HS CODE 9018, 2019–2024      63

5.11.2      EXPORT DATA FOR HS CODE 9018, 2019–2024      63

5.12         REGULATORY ANALYSIS               64

5.12.1      REGULATORY LANDSCAPE         64

5.12.1.1  North America      64

5.12.1.1.1                US           64

5.12.1.1.2                Canada   65

5.12.1.2  Europe   66

5.12.1.3  Asia Pacific            66

5.12.1.3.1                Japan      66

5.12.1.3.2                China      67

5.12.1.3.3                India       68

5.12.1.4  Latin America       68

5.12.1.5  Middle East & Africa            68

5.12.2      REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  69

5.13         PATENT ANALYSIS          71

5.13.1      PATENT PUBLICATION TREND 71

5.13.2      JURISDICTION AND TOP APPLICANT ANALYSIS                 73

5.13.3      LIST OF PATENTS            73

5.14         KEY CONFERENCES & EVENTS, 2025–2026              75

5.15         PORTER’S FIVE FORCES ANALYSIS           76

5.15.1      THREAT OF NEW ENTRANTS      77

5.15.2      THREAT OF SUBSTITUTES          77

5.15.3      BARGAINING POWER OF BUYERS             77

5.15.4      BARGAINING POWER OF SUPPLIERS       77

5.15.5      INTENSITY OF COMPETITIVE RIVALRY 77

5.16         KEY STAKEHOLDERS & BUYING CRITERIA            77

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           78

5.16.2      BUYING CRITERIA           78

5.17         ADJACENT MARKET ANALYSIS  80

5.17.1      FLEXIBLE ENDOSCOPES MARKET             80

5.18         UNMET NEEDS/END-USER EXPECTATIONS         81

5.19         IMPACT OF AI/GEN AI ON RIGID ENDOSCOPES MARKET                 81

5.19.1      INTRODUCTION              81

5.19.2      AI USE CASES     82

5.19.3      KEY COMPANIES IMPLEMENTING AI      83

5.19.4      FUTURE OF GENERATIVE AI ON RIGID ENDOSCOPES MARKET               83

5.20         IMPACT OF 2025 US TARIFFS ON RIGID ENDOSCOPES MARKET               84

5.20.1      INTRODUCTION              84

5.20.2      KEY TARIFF RATES          85

5.20.3      PRICE IMPACT ANALYSIS             86

5.20.4      IMPACT ON REGION      86

5.20.4.1  North America      86

5.20.4.2  Europe   86

5.20.4.3  Asia Pacific            87

5.20.5      IMPACT ON END-USE INDUSTRY              87

6               RIGID ENDOSCOPES MARKET, BY TYPE 88

6.1           INTRODUCTION              89

6.2           LAPAROSCOPES                89

6.2.1        RISING GLOBAL PREVALENCE OF GYNECOLOGICAL AND

CANCER CONDITIONS TO PROPEL MARKET GROWTH  89

6.3           UROLOGY ENDOSCOPES              90

6.3.1        RISING UROLOGICAL DISORDERS AND TECHNOLOGICAL ADVANCES TO DRIVE GROWTH IN UROLOGY ENDOSCOPES SEGMENT        90

6.4           GYNECOLOGY ENDOSCOPES    91

6.4.1        INCREASING PREVALENCE OF GYNECOLOGICAL CANCERS

AMONG WOMEN TO AID MARKET GROWTH       91

6.5           ARTHROSCOPES               92

6.5.1        RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH             92

6.6           CYSTOSCOPES  94

6.6.1        RISING BLADDER CANCER CASES AND MINIMALLY INVASIVE

BENEFITS TO DRIVE CYSTOSCOPES MARKET GROWTH 94

6.7           NEUROENDOSCOPES    95

6.7.1        RISING NEUROLOGICAL DISORDERS AND INVESTMENTS IN ADVANCED CARE TO DRIVE MARKET GROWTH             95

6.8           OTHER RIGID ENDOSCOPES      97

7               RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE                 98

7.1           INTRODUCTION              99

7.2           SURGICAL USAGE            99

7.2.1        RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH    99

7.3           DIAGNOSTIC USAGE      100

7.3.1        GROWING DEMAND FOR OFFICE-BASED ENT, GYNECOLOGY, AND UROLOGY PROCEDURES TO ACCELERATE GROWTH             100

8               RIGID ENDOSCOPES MARKET, BY APPLICATION                 102

8.1           INTRODUCTION              103

8.2           LAPAROSCOPY 103

8.2.1        BROAD CLINICAL APPLICABILITY AND STRONG PROCEDURAL DEMAND ACROSS DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO AID GROWTH          103

8.3           UROLOGY ENDOSCOPY                105

8.3.1        RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO FUEL MARKET             105

8.4           ARTHROSCOPY 106

8.4.1        INCREASING PREVALENCE OF ARTHRITIS AMONG AGING POPULATION TO SPUR GROWTH              106

8.5           NEUROENDOSCOPY      108

8.5.1        FAVORABLE GOVERNMENT AND PRIVATE SECTOR POLICIES

TO SUPPORT ADOPTION OF NEUROENDOSCOPES         108

8.6           OTHER APPLICATIONS 110

9               RIGID ENDOSCOPES MARKET, BY END USER      111

9.1           INTRODUCTION              112

9.2           HOSPITALS         112

9.2.1        ROBUST SURGICAL INFRASTRUCTURE AND LARGE PATIENT BASE

TO FOSTER GROWTH    112

9.3           AMBULATORY SURGERY CENTERS          113

9.3.1        GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND

TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET                 113

9.4           CLINICS                115

9.4.1        RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND

DECENTRALIZED HEALTHCARE TO AID GROWTH           115

9.5           OTHER END USERS         116

10            RIGID ENDOSCOPES MARKET, BY REGION           117

10.1         INTRODUCTION              118

10.2         NORTH AMERICA             119

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 120

10.2.2      US           123

10.2.2.1  US to dominate North American rigid endoscopes

market during forecast period             123

10.2.3      CANADA               125

10.2.3.1  Rising chronic disease prevalence among aging

population to drive market 125

10.3         EUROPE               127

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      127

10.3.2      GERMANY           130

10.3.2.1  Germany to dominate European rigid endoscopes market                 130

10.3.3      UK          132

10.3.3.1  Increased aging population, high cancer prevalence,

and strong healthcare infrastructure to drive market growth        132

10.3.4      FRANCE                134

10.3.4.1  Increase in health expenditure and high prevalence of

cancer to stimulate market growth    134

10.3.5      ITALY    136

10.3.5.1  Increasing prevalence of chronic diseases to boost adoption                 136

10.3.6      SPAIN    137

10.3.6.1  Rising aging population to drive market growth              137

10.3.7      REST OF EUROPE             139

10.4         ASIA PACIFIC     141

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 141

10.4.2      CHINA  145

10.4.2.1  China to dominate Asia Pacific rigid endoscopes

market during forecast period             145

10.4.3      JAPAN   147

10.4.3.1  Increasing chronic disease prevalence and rising geriatric

population to drive growth 147

10.4.4      INDIA    148

10.4.4.1  Rising osteoarthritis and cancer prevalence to drive market growth    148

10.4.5      AUSTRALIA         150

10.4.5.1  Advancing healthcare infrastructure to support rigid endoscopes adoption in Australia            150

10.4.6      SOUTH KOREA  152

10.4.6.1  Super-aged society and high disease prevalence to drive

growth in South Korean market         152

10.4.7      REST OF ASIA PACIFIC   154

10.5         LATIN AMERICA                155

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 155

10.5.2      BRAZIL 158

10.5.2.1  Brazil to account for largest share of Latin American market                 158

10.5.3      MEXICO                160

10.5.3.1  Increasing minimally invasive procedures to support rigid endoscopes adoption            160

10.5.4      REST OF LATIN AMERICA             161

10.6         MIDDLE EAST & AFRICA                163

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 163

10.6.2      GCC COUNTRIES              166

10.6.2.1  High healthcare investments and hospital expansions to drive market growth       166

10.6.3      REST OF MIDDLE EAST & AFRICA             168

11            COMPETITIVE LANDSCAPE         170

11.1         INTRODUCTION              170

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            170

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS

IN RIGID ENDOSCOPES MARKET               170

11.3         REVENUE ANALYSIS, 2020–2024  171

11.4         MARKET SHARE ANALYSIS, 2024                 172

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 175

11.5.1      STARS   175

11.5.2      EMERGING LEADERS     175

11.5.3      PERVASIVE PLAYERS      175

11.5.4      PARTICIPANTS 175

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         177

11.5.5.1  Company footprint               177

11.5.5.2  Region footprint   178

11.5.5.3  Type footprint       179

11.5.5.4  Application footprint            180

11.5.5.5  End-user footprint                181

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        181

11.6.1      PROGRESSIVE COMPANIES         181

11.6.2      RESPONSIVE COMPANIES            181

11.6.3      DYNAMIC COMPANIES  182

11.6.4      STARTING BLOCKS         182

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 183

11.6.5.1  Detailed list of key startups/SMEs    183

11.6.5.2  Competitive benchmarking of key startups/SMEs          184

11.7         COMPANY VALUATION & FINANCIAL METRICS 185

11.7.1      FINANCIAL METRICS      185

11.7.2      COMPANY VALUATION 185

11.8         BRAND/PRODUCT COMPARISON             186

11.9         COMPETITIVE SCENARIO             186

11.9.1      PRODUCT LAUNCHES   186

11.9.2      DEALS  187

12            COMPANY PROFILES      188

12.1         KEY PLAYERS     188

12.1.1      OLYMPUS CORPORATION           188

12.1.1.1  Business overview 188

12.1.1.2  Products offered   189

12.1.1.3  Recent developments           191

12.1.1.3.1                Deals      191

12.1.1.4  MnM view              191

12.1.1.4.1                Right to win           191

12.1.1.4.2                Strategic choices   192

12.1.1.4.3                Weaknesses & competitive threats     192

12.1.2      KARL STORZ SE & CO. KG             193

12.1.2.1  Business overview 193

12.1.2.2  Products offered   193

12.1.2.3  Recent developments           195

12.1.2.3.1                Product launches  195

12.1.2.3.2                Deals      195

12.1.2.4  MnM view              196

12.1.2.4.1                Right to win           196

12.1.2.4.2                Strategic choices   196

12.1.2.4.3                Weaknesses & competitive threats     196

12.1.3      STRYKER              197

12.1.3.1  Business overview 197

12.1.3.2  Products offered   198

12.1.3.3  MnM view              199

12.1.3.3.1                Right to win           199

12.1.3.3.2                Strategic choices   199

12.1.3.3.3                Weaknesses & competitive threats     199

12.1.4      SMITH+NEPHEW              200

12.1.4.1  Business overview 200

12.1.4.2  Products offered   201

12.1.4.3  MnM view              202

12.1.4.3.1                Right to win           202

12.1.4.3.2                Strategic choices   202

12.1.4.3.3                Weaknesses & competitive threats     202

12.1.5      B. BRAUN SE       203

12.1.5.1  Business overview 203

12.1.5.2  Products offered   204

12.1.5.3  MnM view              205

12.1.5.3.1                Right to win           205

12.1.5.3.2                Strategic choices   205

12.1.5.3.3                Weaknesses & competitive threat      205

12.1.6      MEDTRONIC      206

12.1.6.1  Business overview 206

12.1.6.2  Products offered   207

12.1.6.3  Recent developments           208

12.1.6.3.1                Deals      208

12.1.7      NIPRO   209

12.1.7.1  Business overview 209

12.1.7.2  Products offered   210

12.1.8      RICHARD WOLF GMBH 211

12.1.8.1  Business overview 211

12.1.8.2  Products offered   211

12.1.8.3  Recent developments           212

12.1.8.3.1                Deals      212

12.1.9      CONMED CORPORATION             213

12.1.9.1  Business overview 213

12.1.9.2  Products offered   214

12.1.10   ARTHREX, INC. 215

12.1.10.1                 Business overview 215

12.1.10.2                 Products offered   215

12.2         OTHER PLAYERS              216

12.2.1      FUJIFILM CORPORATION             216

12.2.2      HOLOGIC, INC. 217

12.2.3      SHANGRAO WS MEDTECH CO., LTD.      218

12.2.4      ATMOS MEDIZINTECHNIK GMBH & CO. KG         219

12.2.5      HENKE-SASS WOLF         220

12.2.6      RUDOLF MEDICAL GMBH + CO. KG         221

12.2.7      ENDOMED SYSTEMS GMBH        222

12.2.8      TELEFLEX INCORPORATED        223

12.2.9      INTEGRATED ENDOSCOPY         224

12.2.10   NEOSCOPE INC.                225

12.2.11   ECLERIS                226

12.2.12   NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD                 227

12.2.13   KASHMIR SURGICAL WORKS       228

12.2.14   OPTOMIC            229

12.2.15   HIPP ENDOSKOP SERVICE GMBH             230

13            APPENDIX           231

13.1         DISCUSSION GUIDE        231

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                237

13.3         CUSTOMIZATION OPTIONS        239

13.4         RELATED REPORTS         239

13.5         AUTHOR DETAILS           240

LIST OF TABLES

TABLE 1                RIGID ENDOSCOPES MARKET: INCLUSIONS & EXCLUSIONS      25

TABLE 2                STANDARD CURRENCY CONVERSION RATES, 2019–2024              26

TABLE 3                RIGID ENDOSCOPES MARKET: STUDY ASSUMPTIONS  39

TABLE 4                RIGID ENDOSCOPES MARKET: RISK ASSESSMENT     40

TABLE 5                PRODUCT RECALLS BY KEY PLAYERS, 2024–2025                 53

TABLE 6                AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY KEY PLAYER,

2022–2024 (USD)                56

TABLE 7                AVERAGE SELLING PRICE TREND OF RIGID ENDOSCOPES, BY REGION,

2022–2024 (USD)                56

TABLE 8                IMPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND)                 63

TABLE 9                EXPORT DATA FOR RIGID ENDOSCOPES UNDER HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND)                 64

TABLE 10              CLASSIFICATION OF MEDICAL DEVICES BY US FDA        65

TABLE 11              US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS              65

TABLE 12              CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS      66

TABLE 13              CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN    67

TABLE 14              NMPA MEDICAL DEVICES CLASSIFICATION                 67

TABLE 15              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  69

TABLE 16              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 69

TABLE 17              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  70

TABLE 18              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  70

TABLE 19              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  71

TABLE 20              RIGID ENDOSCOPES MARKET: LIST OF PATENTS, 2022−2025      73

TABLE 21              RIGID ENDOSCOPES MARKET: LIST OF KEY CONFERENCES & EVENTS,

JANUARY 2025–DECEMBER 2026 75

TABLE 22              RIGID ENDOSCOPES MARKET: PORTER’S FIVE FORCES                76

TABLE 23              INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF

TOP THREE APPLICATIONS        78

TABLE 24              KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 79

TABLE 25              RIGID ENDOSCOPES MARKET: UNMET NEEDS/END-USER EXPECTATIONS          81

TABLE 26              KEY COMPANIES IMPLEMENTING AI IN RIGID ENDOSCOPES MARKET 83

TABLE 27              US-ADJUSTED RECIPROCAL TARIFF RATES                 85

TABLE 28              KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RIGID ENDOSCOPES             85

TABLE 29              RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)       89

TABLE 30              LAPAROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       90

TABLE 31              UROLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     91

TABLE 32              GYNECOLOGY ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     92

TABLE 33              ARTHROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       93

TABLE 34              CYSTOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)       94

TABLE 35              NEUROENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)            96

TABLE 36              OTHER RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     97

TABLE 37              RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION)            99

TABLE 38              RIGID ENDOSCOPES MARKET FOR SURGICAL USAGE, BY COUNTRY,

2023–2030 (USD MILLION)            100

TABLE 39              RIGID ENDOSCOPES MARKET FOR DIAGNOSTIC USAGE, BY COUNTRY,

2023–2030 (USD MILLION)            101

TABLE 40             RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)            103

TABLE 41              RIGID ENDOSCOPES MARKET FOR LAPAROSCOPY, BY COUNTRY,

2023–2030 (USD MILLION)            104

TABLE 42              RIGID ENDOSCOPES MARKET FOR UROLOGY ENDOSCOPY, BY COUNTRY,

2023–2030 (USD MILLION)            106

TABLE 43              RIGID ENDOSCOPES MARKET FOR ARTHROSCOPY, BY COUNTRY,

2023–2030 (USD MILLION)            107

TABLE 44              RIGID ENDOSCOPES MARKET FOR NEUROENDOSCOPY, BY COUNTRY,

2023–2030 (USD MILLION)            109

TABLE 45              RIGID ENDOSCOPES MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 46              RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)            112

TABLE 47              RIGID ENDOSCOPES MARKET FOR HOSPITALS, BY COUNTRY,

2023–2030 (USD MILLION)            113

TABLE 48              RIGID ENDOSCOPES MARKET FOR AMBULATORY SURGERY CENTERS,

BY COUNTRY, 2023–2030 (USD MILLION)               114

TABLE 49              RIGID ENDOSCOPES MARKET FOR CLINICS, BY COUNTRY,

2023–2030 (USD MILLION)            115

TABLE 50              RIGID ENDOSCOPES MARKET FOR OTHER END USERS, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 51              RIGID ENDOSCOPES MARKET, BY REGION, 2023–2030 (USD MILLION)            119

TABLE 52              RIGID ENDOSCOPES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)  119

TABLE 53              NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            121

TABLE 54              NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            121

TABLE 55              NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  122

TABLE 56              NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            122

TABLE 57              NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            123

TABLE 58              NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            123

TABLE 59              US: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            124

TABLE 60              US: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            124

TABLE 61              US: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              125

TABLE 62              US: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)            125

TABLE 63              CANADA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                126

TABLE 64              CANADA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            126

TABLE 65              CANADA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            126

TABLE 66              CANADA: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                127

TABLE 67              EUROPE: RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     128

TABLE 68              EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                128

TABLE 69              EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS)     129

TABLE 70              EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            129

TABLE 71              EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            129

TABLE 72              EUROPE: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                130

TABLE 73              GERMANY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                131

TABLE 74              GERMANY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            131

TABLE 75              GERMANY: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            131

TABLE 76              GERMANY: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            132

TABLE 77              UK: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            133

TABLE 78              UK: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            133

TABLE 79              UK: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              133

TABLE 80             UK: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)            134

TABLE 81              FRANCE: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                134

TABLE 82              FRANCE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            135

TABLE 83              FRANCE: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            135

TABLE 84              FRANCE: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                135

TABLE 85              ITALY: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            136

TABLE 86              ITALY: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            136

TABLE 87              ITALY: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              137

TABLE 88              ITALY: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                137

TABLE 89              SPAIN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            138

TABLE 90              SPAIN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            138

TABLE 91              SPAIN: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            138

TABLE 92              SPAIN: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                139

TABLE 93             REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            139

TABLE 94             REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            140

TABLE 95             REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            140

TABLE 96             REST OF EUROPE: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            140

TABLE 97              ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            142

TABLE 98              ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                143

TABLE 99              ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  143

TABLE 100            ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            144

TABLE 101            ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            144

TABLE 102            ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            144

TABLE 103            CHINA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            145

TABLE 104            CHINA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            146

TABLE 105            CHINA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            146

TABLE 106            CHINA: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                146

TABLE 107            JAPAN: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            147

TABLE 108            JAPAN: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            147

TABLE 109            JAPAN: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            148

TABLE 110            JAPAN: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                148

TABLE 111            INDIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            149

TABLE 112            INDIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            149

TABLE 113            INDIA: RIGID ENDOSCOPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              150

TABLE 114            INDIA: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                150

TABLE 115            AUSTRALIA: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                151

TABLE 116            AUSTRALIA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            151

TABLE 117            AUSTRALIA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            151

TABLE 118            AUSTRALIA: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            152

TABLE 119            SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            152

TABLE 120            SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            153

TABLE 121            SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            153

TABLE 122            SOUTH KOREA: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            153

TABLE 123            REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            154

TABLE 124            REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            154

TABLE 125            REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            155

TABLE 126            REST OF ASIA PACIFIC: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            155

TABLE 127            LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            156

TABLE 128            LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            156

TABLE 129            LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  157

TABLE 130            LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            157

TABLE 131            LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            157

TABLE 132            LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            158

TABLE 133            BRAZIL: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)            158

TABLE 134            BRAZIL: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            159

TABLE 135            BRAZIL: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            159

TABLE 136            BRAZIL: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                159

TABLE 137            MEXICO: RIGID ENDOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION)                160

TABLE 138            MEXICO: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            160

TABLE 139            MEXICO: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            161

TABLE 140            MEXICO: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030 (USD MILLION)                161

TABLE 141            REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            162

TABLE 142            REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION)                 162

TABLE 143            REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            163

TABLE 144            REST OF LATIN AMERICA: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            163

TABLE 145            MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY REGION,

2023–2030 (USD MILLION)            164

TABLE 146            MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            164

TABLE 147            MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (THOUSAND UNITS)  165

TABLE 148            MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2023–2030 (USD MILLION)                 165

TABLE 149            MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            165

TABLE 150            MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            166

TABLE 151          GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY TYPE,

2023–2030 (USD MILLION)            167

TABLE 152          GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE,

2023–2030 (USD MILLION)            167

TABLE 153          GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            167

TABLE 154          GCC COUNTRIES: RIGID ENDOSCOPES MARKET, BY END USER,

2023–2030 (USD MILLION)            168

TABLE 155            REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         168

TABLE 156            REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,

BY CLINICAL USAGE, 2023–2030 (USD MILLION) 169

TABLE 157            REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,

BY APPLICATION, 2023–2030 (USD MILLION)       169

TABLE 158            REST OF MIDDLE EAST & AFRICA: RIGID ENDOSCOPES MARKET,

BY END USER, 2023–2030 (USD MILLION)               169

TABLE 159            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN

RIGID ENDOSCOPES MARKET    170

TABLE 160            RIGID ENDOSCOPES MARKET: DEGREE OF COMPETITION 173

TABLE 161            RIGID ENDOSCOPES MARKET: REGION FOOTPRINT       178

TABLE 162            RIGID ENDOSCOPES MARKET: TYPE FOOTPRINT       179

TABLE 163            RIGID ENDOSCOPES MARKET: APPLICATION FOOTPRINT       180

TABLE 164            RIGID ENDOSCOPES MARKET: END-USER FOOTPRINT       181

TABLE 165            RIGID ENDOSCOPES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS             183

TABLE 166            RIGID ENDOSCOPES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY TYPE AND REGION     184

TABLE 167            RIGID ENDOSCOPES MARKET: PRODUCT LAUNCHES,

JANUARY 2022–SEPTEMBER 2025                186

TABLE 168            RIGID ENDOSCOPES MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025   187

TABLE 169            OLYMPUS CORPORATION: COMPANY OVERVIEW          188

TABLE 170            OLYMPUS CORPORATION: PRODUCTS OFFERED             189

TABLE 171            OLYMPUS CORPORATION: DEALS, JANUARY 2022–SEPTEMBER 2025   191

TABLE 172            KARL STORZ SE & CO. KG: COMPANY OVERVIEW                 193

TABLE 173            KARL STORZ SE & CO. KG: PRODUCTS OFFERED                 193

TABLE 174          KARL STORZ SE & CO. KG: PRODUCT LAUNCHES,

JANUARY 2022–SEPTEMBER 2025                195

TABLE 175            KARL STORZ SE & CO. KG: DEALS, JANUARY 2022–SEPTEMBER 2025   195

TABLE 176            STRYKER: COMPANY OVERVIEW               197

TABLE 177            STRYKER: PRODUCTS OFFERED                198

TABLE 178            SMITH+NEPHEW: COMPANY OVERVIEW                 200

TABLE 179            SMITH+NEPHEW: PRODUCTS OFFERED                 201

TABLE 180            B. BRAUN SE: COMPANY OVERVIEW       203

TABLE 181            B. BRAUN SE: PRODUCTS OFFERED        204

TABLE 182            MEDTRONIC: COMPANY OVERVIEW       206

TABLE 183            MEDTRONIC: PRODUCTS OFFERED        207

TABLE 184            MEDTRONIC: DEALS, JANUARY 2022–SEPTEMBER 2025              208

TABLE 185            NIPRO: COMPANY OVERVIEW   209

TABLE 186            NIPRO: PRODUCTS OFFERED    210

TABLE 187            RICHARD WOLF GMBH: COMPANY OVERVIEW                 211

TABLE 188            RICHARD WOLF GMBH: PRODUCTS OFFERED                 211

TABLE 189            RICHARD WOLF GMBH: DEALS, JANUARY 2022–SEPTEMBER 2025              212

TABLE 190            CONMED CORPORATION: COMPANY OVERVIEW          213

TABLE 191            CONMED CORPORATION: PRODUCTS OFFERED             214

TABLE 192            ARTHREX, INC.: COMPANY OVERVIEW  215

TABLE 193            ARTHREX, INC.: PRODUCTS OFFERED   215

TABLE 194            FUJIFILM CORPORATION: COMPANY OVERVIEW          216

TABLE 195            HOLOGIC, INC.: COMPANY OVERVIEW  217

TABLE 196            SHANGRAO WS MEDTECH CO., LTD.: COMPANY OVERVIEW          218

TABLE 197            ATMOS MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW   219

TABLE 198            HENKE-SASS WOLF: COMPANY OVERVIEW                 220

TABLE 199            RUDOLF MEDICAL GMBH + CO. KG: COMPANY OVERVIEW          221

TABLE 200            ENDOMED SYSTEMS GMBH: COMPANY OVERVIEW          222

TABLE 201            TELEFLEX INCORPORATED: COMPANY OVERVIEW          223

TABLE 202            INTEGRATED ENDOSCOPY: COMPANY OVERVIEW          224

TABLE 203            NEOSCOPE INC.: COMPANY OVERVIEW 225

TABLE 204            ECLERIS: COMPANY OVERVIEW                226

TABLE 205            NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD: COMPANY OVERVIEW               227

TABLE 206            KASHMIR SURGICAL WORKS: COMPANY OVERVIEW          228

TABLE 207            OPTOMIC: COMPANY OVERVIEW             229

TABLE 208            HIPP ENDOSKOP SERVICE GMBH: COMPANY OVERVIEW          230

LIST OF FIGURES

FIGURE 1              RIGID ENDOSCOPES MARKET SEGMENTATION & REGIONAL SCOPE       24

FIGURE 2              RIGID ENDOSCOPES MARKET: YEARS CONSIDERED    26

FIGURE 3              RIGID ENDOSCOPES MARKET: RESEARCH DESIGN                28

FIGURE 4              RIGID ENDOSCOPES MARKET: KEY DATA FROM SECONDARY SOURCES  30

FIGURE 5              RIGID ENDOSCOPES MARKET: KEY PRIMARY SOURCES             31

FIGURE 6              RIGID ENDOSCOPES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS          32

FIGURE 7              RIGID ENDOSCOPES MARKET: KEY DATA FROM PRIMARY SOURCES         33

FIGURE 8              PRIMARY BREAKDOWN OF PRIMARY INTERVIEWS:

BY COMPANY TYPE, DESIGNATION, AND REGION            33

FIGURE 9              RIGID ENDOSCOPES MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS         34

FIGURE 10            RIGID ENDOSCOPES MARKET: TOP-DOWN APPROACH         35

FIGURE 11            IMPACT ANALYSIS OF MARKET DYNAMICS, 2025–2030              36

FIGURE 12            RIGID ENDOSCOPES MARKET: CAGR PROJECTIONS   37

FIGURE 13            RIGID ENDOSCOPES MARKET: DATA TRIANGULATION METHODOLOGY         38

FIGURE 14            RIGID ENDOSCOPES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)       41

FIGURE 15            RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE, 2025 VS. 2030 (USD MILLION)      42

FIGURE 16           RIGID ENDOSCOPES MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)      42

FIGURE 17            RIGID ENDOSCOPES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)      43

FIGURE 18            REGIONAL SNAPSHOT OF RIGID ENDOSCOPES MARKET               44

FIGURE 19            RISING REQUIREMENT FOR ENDOSCOPY TO DIAGNOSE AND TREAT TARGET DISEASES TO DRIVE MARKET GROWTH             45

FIGURE 20            US AND HOSPITALS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN RIGID ENDOSCOPES MARKET IN 2024  46

FIGURE 21            INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD         47

FIGURE 22            MIDDLE EAST & AFRICA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD          47

FIGURE 23            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD    48

FIGURE 24            RIGID ENDOSCOPES MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     49

FIGURE 25            TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS IN RIGID ENDOSCOPES MARKET                 55

FIGURE 26            RIGID ENDOSCOPES MARKET: VALUE CHAIN ANALYSIS            58

FIGURE 27            RIGID ENDOSCOPES MARKET: SUPPLY CHAIN ANALYSIS            59

FIGURE 28            RIGID ENDOSCOPES MARKET: ECOSYSTEM ANALYSIS            60

FIGURE 29            RIGID ENDOSCOPES MARKET: FUNDING SCENARIO AND NUMBER OF DEALS, 2019–2023 (USD MILLION)                 61

FIGURE 30            RIGID ENDOSCOPES MARKET: PATENT ANALYSIS,

JANUARY 2015–SEPTEMBER 2025                72

FIGURE 31            TOP APPLICANTS FOR RIGID ENDOSCOPES, JANUARY 2015−SEPTEMBER 2025              73

FIGURE 32            RIGID ENDOSCOPES MARKET: PORTER’S FIVE FORCES ANALYSIS           76

FIGURE 33            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF TOP THREE APPLICATIONS            78

FIGURE 34            KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 79

FIGURE 35            FLEXIBLE ENDOSCOPES MARKET OVERVIEW                 80

FIGURE 36            AI USE CASES IN RIGID ENDOSCOPES MARKET                 82

FIGURE 37            RIGID ENDOSCOPES MARKET: GEOGRAPHIC SNAPSHOT          118

FIGURE 38            NORTH AMERICA: RIGID ENDOSCOPES MARKET SNAPSHOT       120

FIGURE 39            ASIA PACIFIC: RIGID ENDOSCOPES MARKET SNAPSHOT          142

FIGURE 40            REVENUE ANALYSIS OF KEY PLAYERS IN RIGID ENDOSCOPES MARKET

(2020–2024)          172

FIGURE 41            MARKET SHARE ANALYSIS OF KEY PLAYERS IN

RIGID ENDOSCOPES MARKET (2024)       173

FIGURE 42            RIGID ENDOSCOPES MARKET: COMPANY EVALUATION

MATRIX (KEY PLAYERS), 2024     176

FIGURE 43            RIGID ENDOSCOPES MARKET: COMPANY FOOTPRINT       177

FIGURE 44            RIGID ENDOSCOPES MARKET: COMPANY EVALUATION

MATRIX (STARTUPS/SMES), 2024               182

FIGURE 45            EV/EBITDA OF KEY VENDORS   185

FIGURE 46            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS      185

FIGURE 47            RIGID ENDOSCOPES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     186

FIGURE 48            OLYMPUS CORPORATION: COMPANY SNAPSHOT          189

FIGURE 49            STRYKER: COMPANY SNAPSHOT              198

FIGURE 50            SMITH+NEPHEW: COMPANY SNAPSHOT                 201

FIGURE 51            B. BRAUN SE: COMPANY SNAPSHOT       204

FIGURE 52            MEDTRONIC: COMPANY SNAPSHOT      207

FIGURE 53            NIPRO: COMPANY SNAPSHOT   210

FIGURE 54            CONMED CORPORATION: COMPANY SNAPSHOT          214

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧